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Did Monsanto Pay a Plaintiff to Force
Preemption Appeal? Plus: Judges
Debate Vices and Virtues of Virtual
MDL Hearings
The maker of the Roundup weedkiller insists  a “high-low settlement” with a plaintiff wasn’t designed to create an
appellate ruling.in its long-term favor
By Amanda Bronstad |  April 28, 2021 at 07:33 PM
Welcome to Critical Mass, Law.com’s weekly briefing for class action and mass tort
attorneys. Monsanto insists a “high-low settlement” with a Roundup plaintiff wasn’t
designed to manufacture an appellate ruling. The chairwoman of the U.S. Judicial
Panel on Multidistrict Litigation, which has continued to hold hearings amid the
pandemic, says there is “something missing” in virtual oral arguments. What
does President Joe Biden’s recognition of the Armenian genocide mean for lawyers
representing descendants of the victims?
Feel free to reach out to me with your input. You can email me at abronstad@alm.com,
or follow me on Twitter: @abronstadlaw.
Monsanto Paid Plaintiff to Force Preemption Appeal,
Lawyers Say
A new fight has begun in the Roundup litigation, with lead lawyers in the multidistrict
litigation accusing Monsanto of paying its opponent in an individual case to appeal a
ruling in hopes of winning a key decision on federal preemption.
First the backstory: Monsanto, now owned by Bayer, has insisted that the Federal
Insecticide, Fungicide and Rodenticide Act preempts plaintiffs’ claims that it failed to warn
about Roundup’s link to cancer. Unfortunately for Monsanto, federal and state judges in
5/3/2021 Did Monsanto Pay a Plaintiff to Force Preemption Appeal? Plus: Judges Debate Vices and Virtues of Virtual MDL Hearings | Law.com
https://www.law.com/2021/04/28/did-monsanto-pay-a-plaintiff-to-force-preemption-appeal-plus-judges-debate-vices-and-virtues-of-virtual-mdl-hearings/ 2/2
California, where juries have awarded three verdicts totaling nearly $2.4 billion, have
sided with the plaintiffs on that issue, which affects all Roundup cases. The same issue is
now awaiting rulings from two appeals courts: the U.S. Court of Appeals for the Ninth
Circuit and a California Court of Appeal.
What’s happening now: In an individual case in Georgia, U.S. District Judge R. Stan
Baker, in the Southern District, ruled on Dec. 21 for Monsanto on federal preemption
as to failure-to-warn claims but allowed the plaintiffs to pursue limited claims on
negligence and design defect. Last month, the plaintiff in that case, John Carson,
agreed to settle the remaining claims but appeal the preemption ruling to the U.S. Court
of Appeals for the Eleventh Circuit.
The controversy: Lead counsel in the multidistrict litigation, in a letter to the Eleventh
Circuit, alleged that Monsanto, with the settlement, had manufactured a “pay-to-appeal
scheme”. They say Carson has to fork over nearly $100,000 if he drops his appeal.
Monsanto, on the other hand, calls the arrangement a “high-low settlement,” in which
the $100,000 is the low end of the settlement payment that Carson only has to return if
he breaches the agreement by dropping his appeal.
I reached out to Elizabeth Burch (University of Georgia School of Law), who is
following the issue. She told me:
“It’s really hard to comment on the ‘high-low settlement,’ without being privy to all of its
terms. But it appears to be unlike any high-low agreement I’ve ever seen and it seems
perverse on its face: paying a plaintiff to appeal an issue that the defendants prevailed
on. Of course, the bigger questions are whether it is improper and whether there is a
genuine case or controversy before the Eleventh Circuit.”
